The government has proposed the complete withdrawal of import duty on 51 new raw materials used in the manufacture of active pharmaceutical ingredients (APIs) to make medicines more affordable for consumers in the domestic marke

If the government extends tariff concessions, tax incentives, and technology transfer support to investors, many initial obstacles can be overcome.

Production of active pharmaceutical ingredients (APIs) at the API Industrial Park in Gazaria of Munshiganj will begin next month, with ACME Laboratories set to commission its manufacturing unit despite the lack of gas supply.

Makers of active pharmaceutical ingredients (API) at the API Industrial Park in Gazaria of Munshiganj have fallen into uncertainty as bureaucratic complexities and the lack of gas connections are preventing them from starting production.